Gas chromatographic mass-specific investigation of dextromoramide (Palfium) metabolism in the horse.

This research investigates how the drug Dextromoramide (Palfium) is metabolised in a horse’s body. Using various lab techniques, the experiment found two primary metabolites present in the horse’s urine after administering the drug.

Research Methodology

• The researchers first administered 20 mg of Dextromoramide to a Thoroughbred horse via intravenous injection.
• They then collected urine samples from the horse at multiple intervals post-administration: 2, 4, 6 and 8 hours after.
• The urine was then subjected to enzymatic hydrolysis followed by a solvent extraction process to remove impurities and non-volatile by-products.
• The extracted residue was further cleaned by back-extracting it into 0.1 M sulphuric acid, pH was adjusted to 9, and given another round of solvent extraction.
• The final cleaned-up residue was then ready for gas chromatographic-mass spectrometric analysis.

Results of Gas Chromatographic-Mass Spectrometric Analysis

• Both electron-impact and ammonia chemical-ionisation mass spectra were recorded during the analysis. The mass spectra represent the mass distribution of the sample’s constituents.
• The researchers studied the resulting fragmentation patterns to identify the metabolites present in the horse’s urine after the administration of Dextromoramide.
• Two principle metabolites were identified: 2,2-diphenyl-3-methyl-4-morpholinobutyramide (compound 2) and a product of hydroxylation of one phenyl ring in Dextromoramide (compound 3).

In conclusion, the study provided valuable insights into how Dextromoramide, a potent synthetic opioid analgesic, is metabolised in horses. These findings can be used to make more informed decisions about the usage of this drug in equine medical care. Understanding how a drug metabolises in an organism’s body, and what by-products it produces, is crucial to assessing its efficiency, safety, and potential side effects.